Gerry Brooks and epoxide hydrolases: Four decades to a pharmaceutical

Pest Management Science

Volumn 64, Issue 6, 2008, Pages 594-609

  Morisseau, Christophe ^a   Hammock, Bruce D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asymmetric organic synthesis; Cardiovascular diseases; Juvenile hormone; Xenobiotic metabolism

Indexed keywords

EPOXIDE HYDROLASE; INSECTICIDE; JUVENILE HORMONE;

CARDIOVASCULAR DISEASE; DRUG; ENZYME; FATTY ACID; HORMONE; INSECT; INSECTICIDE; JUVENILE; METABOLISM; OXIDE; PHYSIOLOGICAL RESPONSE; PUBLIC HEALTH; XENOBIOTICS;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CONFERENCE PAPER; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HISTORY; INSECT; MAMMAL; METABOLISM;

ANIMALS; EPOXIDE HYDROLASES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; INSECTICIDES; INSECTS; JUVENILE HORMONES; MAMMALS; MOLECULAR STRUCTURE;

HEXAPODA; MAMMALIA;

EID: 44949226818     PISSN: 1526498X     EISSN: 15264998     Source Type: Journal    
DOI: 10.1002/ps.1583     Document Type: Conference Paper

References (136)

1. Brooks GT, Chlorinated Insecticides. Vol. 1. Technology and Application. CRC Press, Cleveland, OH (1974).
2. Brooks GT, Chlorinated Insecticides. Vol. 2. Biological and Environmental Aspects. CRC Press, Cleveland, OH (1974).
3. Brooks GT, Harrison A and Lewis SE, Cyclodiene epoxide ring hydration by microsomes from mammalian liver and houseflies. Biochem Pharmacol 19:255-273 (1970).
4. Booth J and Boyland E, Metabolism of polycyclic compounds. 5. Formation of 1:2-dihydroxy-1:2-dihydronaphthalenes. Biochem J 44:361-365 (1949).
5. Smith JN, Spencer B and Williams RT, Studies in detoxication; the metabolism of chlorobenzene in the rabbit; isolation of dihydrodihydroxychlorobenzene, p-chlorophenylglucuronide, 4-chlorocatechol glucuronide and p-chlorophenylmercapturic acid. Biochem J 47:284-293 (1950).
6. Leibman KC and Ortiz E, Oxidation of indene in liver microsomes. Mol Pharmacol 4:201-207 (1968).
7. Jerina D, Daly J, Wiltkop B, Zaltzman-Nirenberg P and Udenfriend S, Role of arene oxide-oxepin system in the metabolism of aromatic substrates. I. In vitro conversion of benzene oxide to a premercapturic acid and a dihydrodiol. Arch Biochem Biophys 128:176-183 (1968).
8. Maynert EW, Foreman RL and Watabe T, Epoxides as obligatory intermediates in the metabolism of olefins to glycols. J Biol Chem 245:5234-5238 (1970).
9. Jerina D, Daly JW, Wiltkop B, Zaltzman-Nirenberg P and Udenfriend S, 1,2-Naphthalene oxide as an intermediate in the microsomal hydroxylation of naphthalene. Biochemistry 9:147-156 (1970).
10. Brooks GT, Insect epoxide hydrase inhibition by juvenile hormone analogs and metabolic inhibitors. Nature (London) 245:382-384 (1973).
11. Brooks GT, Inhibitors of cyclodiene epoxide ring hydrating enzymes of the blowfly, Calliphora erythrocephala. Pestic Sci 5:177-183 (1974).
12. Brooks GT, Effects of metabolic inhibitors on insect epoxide hydratases. Biochem Soc Trans 1:1305-1305 (1974).
13. Slade M, Brooks GT, Hetnarski HK and Wilkinson CF, Inhibition of the enzymatic hydration of the epoxide HEOM [1,2,3,4,9,9-hexachloro-6,7-epoxy-1,4, 4a,5,6,7,8,8a-octahydro-1,4-methanonaphthalene] in insects. Pestic Biochem Physiol 5:35-46 (1975).
14. Craven ACC, Brooks GT and Walker CH, The inhibition of HEOM epoxide hydrase in mammalian liver microsomes and insect pupal homogenates. Pestic Biochem Physiol 6:132-141 (1976).
15. Watabe T and Kanehira S, Solubilization of epoxide hydrolase from liver microsomes. Chem Pharm Bull. 18:1295-1296 (1970).
16. Lu AY, Ryan D, Jerina DM, Daly JW and Levin W, Liver microsomal expoxide hydrase. Solubilization, purification, and characterization. J Biol Chem 250:8283-8288 (1975).
17. Watabe T, Akamatsu K and Kiyonaga K, Stereoselective hydrolysis of cis- and trans-stilbene oxides by hepatic microsomal epoxide hydrolase. Biochem Biophys Res Commun 44:199-204 (1971).
18. Watabe T, Kiyonaga K, Akamatsu K and Hara S, Stereoselective hydrolysis of 2,3-epoxysteroids by hepatic microsomal epoxide hydrolase. Biochem Biophys Res Commun 43:1252-1258 (1971).
19. Gill SS, Ota K and Hammock BD, Radiometric assays for mammalian epoxide hydrolases and glutathione S-transferase. Anal Biochem 131:273-282 (1983).
20. Brooks GT, Mechanisms of resistance of the adult housefly (Musca domestica) to 'cyclodiene' insecticides. Nature (London) 186:96-98 (1960).
21. Takahashi W, Saidin D, Takei G and Wong L, Organochloride pesticide residues in human milk in Hawaii, 1979-80. Bull Environ Contam Toxicol 27:506-511 (1981).
22. Mullin CA and Croft BA, trans-Epoxide hydrolase: a key indicator enzyme for herbivory in arthropods. Cell Molec Life Sci 40:176-178 (1984).
23. Mullin CA, Adaptive relationships of epoxide hydrolase in herbivorous arthropods. J Chem Ecol 14:1867-1888 (1988).
24. Jansen M, Baars AJ and Breimer DD, Microsomal and cytosolic epoxide hydrolase in Drosophila melanogaster. Biochem Pharmacol 35:2229-2232 (1986).
25. Taniai K, Inceoglu AB, Yukuhiro K and Hammock BD, Characterization and cDNA cloning of a clofibrate-inducible microsomal epoxide hydrolase in Drosophila melanogaster. Eur J Biochem 270:4696-4705 (2003).
26. Ottea JA, Plapp FW and Hammock BD, Biochemical and genetic analysis of epoxide-metabolizing enzymes in susceptible and resistant house flies, Musca domestica L. Pestic Biochem Physiol 29:138-145 (1987).
27. Ottea JA, Harshman LG and Hammock BD, Novel assay for determining the metabolic fate of juvenile hormone III: a study with Drosophila melanogaster. Arch Insect Biochem Physiol 8:25-37 (1988).
28. Slade M and Zibitt CH, Metabolism of cecropia juvenile hormone in lepidopterans. Pestic Chem 3:45-58 (1971).
29. Slade M and Zibitt CH, Metabolism of cecropia juvenile hormone in insects and in mammals, in Insect Juvenile Hormones: Chemistry and Action, ed. by Menn JJ and Beroza M. Academic Press, New York, NY, pp. 155-176 (1972).
30. Gill SS, Hammock BD, Yamamoto I and Casida JE, Preliminary chromatographic studies on the metabolites and photodecomposition products of the juvenoid 1-(4′-ethylphenoxy-6,7-epoxy-3,7-dimethyl-2-octene, in Insect Juvenile Hormones: Chemistry and Action, ed. by Menn JJ and Beroza M. Academic Press, New York, NY, pp. 177-189 (1972).
31. Hammock BD and Quistad GB, The degradative metabolism of juvenoids by insects, in The Juvenile Hormones, ed. by Gilbert LE. Plenum Press, New York, NY, pp. 374-393 (1976).
32. Hammock BD, Regulation of juvenile hormone titer: degradation, in Comprehensive Insect Physiology, Biochemistry, and Pharmacology, ed. by Kerkut GA and Gilbert LI. Pergamon Press, New York, NY, pp. 431-472 (1985).
33. Prestwich GD, Wojtasek H, Lentz AJ and Rabinovich JM, Biochemistry of proteins that bind and metabolize juvenile hormones. Arch Insect Biochem Physiol 32:407-419 (1996).
34. Gilbert LI, Granger NA and Roe RM, The juvenile hormones: historical facts and speculations on future research directions. Insect Biochem Mol Biol 30:617-644 (2000).
35. Oesch F, Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 3:305-340 (1973).
36. Hammock BD and Mumby SM, Inhibition of epoxidation of methyl farnesoate to juvenile hormone III by cockroach corpus allatum homogenates. Pestic Biochem Physiol 9:39-47 (1978).
37. Slade M and Wilkinson CF, Juvenile hormone analogs: a possible case of mistaken identity? Science (Washington) 181:672-674 (1973).
38. Solomon KR and Walker WF, Letter: juvenile hormone synergists: a possible case of hasty conclusion? Science (Washington) 185:461-462 (1974).
39. Mullin CA and Wilkinson CF, Purification of an epoxide hydrolase from the midgut of the southern armyworm (Spodoptera eridania). Insect Biochem 10:681-691 (1980).
40. Mullin CA and Wilkinson CF, Insect epoxide hydrolase: properties of a purified enzyme from the southern armyworm (Spodoptera eridania). Pestic Biochem Physiol 14:192-207 (1980).
41. Sparks TC and Hammock BD, Comparative inhibition of the juvenile hormone esterases from Trichoplusia ni, Tenebrio molitor and Musca domestica. Pestic Biochem Physiol 14:290-302 (1980).
42. Abdel-Aal YAI and Hammock BD, Transition state analogs as ligands for affinity purification of juvenile hormone esterase. Science (Washington) 233:1073-1076 (1986).
43. Hammock BD, Bonning BC, Possee RD, Hanzlik TN and Maeda S, Expression and effects of the juvenile hormone esterase in a baculovirus vector. Nature (London) 344:458-461 (1990).
44. Tan A, Tanaka H, Tamura T and Shiotsuki T, Precocious metamorphosis in transgenic silkworms overexpressing juvenile hormone esterase. Proc Natl Acad Sci USA 102:11751-11756 (2005).
45. Halarnkar PP, Jackson GP, Straub KM and Schooley DA, Juvenile hormone catabolism in Manduca sexta: homologue selectivity of catabolism and identification of a diolphosphate conjugate as a major end product. Cell Mol Life Sci 49:988-994 (1993).
46. Khalil SMS, Anspaugh DD and Roe RM, Role of juvenile hormone esterase and epoxide hydrolase in reproduction of the cotton bollworm, Helicoverpa zea. J Insect Physiol 52:669-678 (2006).
47. Mullin CA and Hammock BD, Chalcone oxides - potent selective inhibitors of cytosolic epoxide hydrolase. Arch Biochem Biophys 216:423-439 (1982).
48. Dietze EC, Kuwano E, Casas J and Hammock BD, Inhibition of cytosolic epoxide hydrolase by trans-3-phenylglycidols. Biochem Pharmacol 42:1163-1175 (1991).
49. Dietze EC, Casas J, Kuwano E and Hammock BD, Inhibition of epoxide hydrolase from human, monkey, bovine, rabbit, and murine liver by trans-3-phenylglycidols. Comp Biochem Physiol 104B:309-314 (1993).
50. Linderman RJ, Roe RM, Harris SV and Thompson DM, Inhibition of insect juvenile hormone epoxide hydrolase: asymmetric synthesis and assay of glycidol-ester and epoxyester inhibitors of Trichoplusia ni epoxide hydrolase. Insect Biochem Mol Biol 30:767-774 (2000).
51. Touhara K and Prestwich GD, Juvenile hormone epoxide hydrolase. Photoaffinity labeling, purification, and characterization from tobacco hornworm eggs. J Biol Chem 268:19604-19609 (1993).
52. Debernard S, Morisseau C, Severson TF, Feng L, Wojtasek H, Prestwich GD et al, Expression and characterization of the recombinant juvenile hormone epoxide hydrolase (JHEH) from Manduca sexta. Insect Biochem Mol Biol 28:409-419 (1998).
53. Zhang QR, Xu WH, Chen FS and Li S, Molecular and biochemical characterization of juvenile hormone epoxide hydrolase from the silkworm, Bombyx mori. Insect Biochem Mol Biol 35:153-164 (2005).
54. Roe RM, Kallapur V, Linderman RJ, Viviani F, Harris SV, Walker EA et al, Mechanism of action and cloning of epoxide hydrolase from the cabbage looper, Trichoplusia ni. Arch Insect Biochem Physiol 32:527-535 (1996).
55. VanHook Harris S, Marin Thompson D, Linderman RJ, Tomalski MD and Roe RM, Cloning and expression of a novel juvenile hormone-metabolizing epoxide hydrolase during larval-pupal metamorphosis of the cabbage looper, Trichoplusia ni. Insect Mol Biol 8:85-96 (1999).
56. Keiser KC, Brandt KS, Silver GM and Wisnewski N, Cloning, partial purification and in vivo developmental profile of expression of the juvenile hormone epoxide hydrolase of Ctenocephalides felis. Arch Insect Biochem Physiol 50:191-206 (2002).
57. Severson TF, Goodrow MH, Morisseau C, Dowdy DL and Hammock BD, Urea and amide-based inhibitors of the juvenile hormone epoxide hydrolase of the tobacco hornworm (Manduca sexta: Sphingidae). Insect Biochem Mol Biol 32:1741-1756 (2002).
58. Morisseau C, Goodrow MH, Dowdy D, Zheng J, Greene JF, Sanborn JR et al, Potent urea and carbamate inhibitors of soluble epoxide hydrolases. Proc Natl Acad Sci USA 96:8849-8854 (1999).
59. Morisseau C, Newman JW, Dowdy DL, Goodrow MH and Hammock BD, Inhibition of microsomal epoxide hydrolases by ureas, amides and amines. Chem Res Tox 14:409-415 (2001).
60. Renou M and Guerrero A, Insect parapheromones in olfaction: research and semiochemical-based pest control strategies. Annu Rev Entomol 48:605-630 (2000).
61. Plettner E, Insect pheromone olfaction: new targets for the design of species selective pest control agents. Curr Med Chem 9:1075-1085 (2002).
62. Graham SM and Prestwich GD, Synthesis and inhibitory properties of pheromone analogues for the epoxide hydrolase of gypsy moth. J Org Chemistry 59:295-296 (1994).
63. Marini S, Xenobiotic-metabolizing enzymes in pig nasal and hepatic tissues. Xenobiotica 28:923-935 (1998).
64. Newman JW, Morisseau C and Hammock BD, Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog Lipid Res 44:1-51 (2005).
65. Hammock BD, Grant D and Storms D, Epoxide hydrolases, in Comprehensive Toxicology, ed. by Sipes I, McQueen C and Gandolfi A. Pergamon Press, Oxford, UK, pp. 283-305 (1997).
66. Wixtrom RN and Hammock BD, Membrane-bound and soluble-fraction epoxide hydrolases: methodological aspects, in Biochemical Pharmacology and Toxicology. Vol. 1, ed. by Zakim D and Vessey DA. John Wiley & Sons, Inc., New York, NY, pp 1-93 (1985).
67. Sevanian A, Stein RA and Mead JF, Metabolism of epoxidized phosphatidylcholine by phospholipase A2 and epoxide hydrolase. Lipids 16:781-789 (1981).
68. Morisseau C and Hammock BD, Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu Rev Pharmacol Toxicol 45:311-333 (2005).
69. Guengerich FP, Johnson WW, Shimada T, Ueng YF, Yamazaki H and Langouet S, Activation and detoxication of aflatoxin B1. Mutat Res 402:121-128 (1998).
70. Walters JM and Combes RD, Activation of benzo[a]pyrene and aflatoxin B1 to mutagenic chemical species by microsomal preparations from rat liver and small intestine in relation to microsomal epoxide hydrolase. Mutagenesis 1:45-48 (1986).
71. Cookson MJ, Sims P and Grover PL, Mutagenicity of epoxides of polycyclic hydrocarbons correlates with carcinogenicity of parent hydrocarbons. Nat New Biol 234:186-187 (1971).
72. Boyland E and Williams K, An enzyme catalyzing the conjugation of epoxides with glutathione. Biochem J 94:190-197 (1965).
73. Armstrong RN, Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol 10:2-18 (1997).
74. Siedegård J and Ekström G, The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect 105:791-799 (1997).
75. Zheng J, Cho M, Brennan P, Chichester C, Buckpitt AR, Jones AD et al, Evidence for quinone metabolites of naphthalene covalently bound to sulfur nucleophiles of proteins of mouse Clara cell after exposure to naphthalene. Chem Res Toxicol 10:1008-1014 (1997).
76. Yoo JH, Kang DS, Chun WH, Lee WJ and Lee AK, Anticonvulsant hypersensitivity syndrome with an epoxide hydrolase defect. Br J Dermatol 140:181-183 (1999).
77. Szeliga J and Dipple A, DNA adducts formation by polycyclic aromatic hydrocarbon dihydrodiol epoxides. Chem Res Toxicol 11:1-11 (1998).
78. Miyata M, Kudo G, Lee YH, Yang TJ, Gelboin HV, Fernandez-Salguero P et al, Targeted disruption of the microsomal epoxide hydrolase gene: microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[α]anthracene. J Biol Chem 274:23963-23968 (1999).
79. von Dippe P, Zhu QS and Levy D, Cell surface expression and bile acid transport function of one topological form of m-epoxide hydrolase. Biochem Biophys Res Commun 309:804-809 (2003).
80. Oesch F, Kaubisch N, Jerina DM and Daly JW, Hepatic epoxide hydrase. Structure-activity relationships for substrates and inhibitors. Biochemistry 10:4858-4866 (1971).
81. Oesch F, Jerina DM, Daly JW and Rice JM, Induction, activation and inhibition of epoxide hydrase: an anomalous prevention of chlorobenzene-induced hepatotoxicity by an inhibitor of epoxide hydrase. Chem Biol Interact 6:189-202 (1973).
82. Kerr BM, Rettie AE, Eddy AC, Loiseau P, Guyot M, Wilensky AJ et al, Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation. Clin Pharmacol Ther 46:82-93 (1989).
83. Kroetz DL, Loiseau P, Guyot M and Levy RH, In vivo and in vitro correlation of microsomal epoxide hydrolase inhibition by progabide. Clin Pharmacol Ther 54:485-497 (1993).
84. Spina E, Pisani F and Perucca E, Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet 31:198-214 (1996).
85. Kerr BM and Levy RH, Unsubstituted amides: new class of potent inhibitors of human microsomal epoxide hydrolase. Drug Metab Dispos 18:540-542 (1990).
86. Abdel-Rahman SZ, Ammenheuser MM, Omiecinski CJ, Wickliffe JK, Rosenblatt JI and Ward JB, Variability in human sensitivity to 1,3-butadiene: influence of polymorphisms in the 5′-flanking region of the microsomal epoxide hydrolase gene (EPHX1). Toxicol Sci 85:624-631 (2005).
87. Monroe DH and Eaton DL, Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouse. Toxicol Appl Pharmacol 90:401-409 (1987).
88. Tanaka K, Kiyosawa N, Watanabe K and Manabe S, Characterization of resistance to bromobenzene-induced hepatotoxicity by microarray. J Toxicol Sci 32:129-134 (2007).
89. Bauer AK, Faiola B, Abernethy DJ, Marchan R, Pluta LJ, Wong VA et al, Male mice deficient in microsomal epoxide hydrolase are not susceptible to benzene-induced toxicity. Toxicol Sci 72:201-209 (2003).
90. Gill SS, Hammock BD and Casida JE, Mammalian metabolism and environmental degradation of the juvenoid 1-(4′-ethylphenoxy)-3,7-dimethyl-6,7- epoxy-trans-2-octene and related compounds. J Ag Food Chem 22:386-395 (1974).
91. Hammock BD, Gill SS, Stamoudis V and Gilbert LI, Soluble mammalian epoxide hydratase: action on juvenile hormone and other terpenoid epoxides. Comp Biochem Physiol 53B:263-265 (1976).
92. Hammock BD, Gill SS, Mumby SM and Ota K, Comparison of epoxide hydrases in the soluble and microsomal fractions of mammalian liver, in Molecular Basis of Environmental Toxicity, ed. by Bhatnagar RS. Ann Arbor Science Publishers, Ann Arbor, MI, pp. 229-272 (1980).
93. Gill S and Hammock BD, Distribution and properties of a mammalian soluble epoxide hydrase. Biochem Pharmacol 29:389-395 (1980).
94. Ota K and Hammock BD, Cytosolic and microsomal epoxide hydrolases: differential properties in mammalian liver. Science (Washington) 207:1479-1481 (1980).
95. Haeggstrom JZ, Tholander F and Wetterholm A, Structure and catalytic mechanisms of leukotriene A4 hydrolase. Prostaglandins Other Lipid Mediat 83:198-202 (2007).
96. Tchen TT and Bloch K, On the conversion of squalene to lanosterol in vitro. J Biol Chem 226:921-930 (1957).
97. Corey EJ, Lin K and Jautelat M, Studies on the action of 2,3-epoxysqualene-sterol cyclase on unnatural substrates produced by alkylidene transfer from sulfonium alkylides to 4,8,13,17,21-pentamethyldocosa-4,8,12,16, 20-pentaenal. J Am Chem Soc 90:2724-2726 (1968).
98. Van Tamelen EE, Sharpless KB, Willett JD, Clayton RB and Burlingame AL, Biological activities of some terminally modified squalene and squalene 2,3-oxide analogs. J Am Chem Soc 89:3920-3922 (1967).
99. Mumby SM and Hammock BD, Substrate selectivity and stereochemistry of enzymatic epoxide hydration in the soluble fraction of mouse liver. Pestic Biochem Physiol 11:275-284 (1979).
100. 14 by cellular fractions of rat liver. J Biol Chem 222:1-15 (1956).
101. Gill SJ, Grant DF, Beetham JK, Chang C and Hammock BD, Peroxisomal proliferation and subcellular localization of soluble epoxide hydrolase: role of peroxisomal targeting sequences, in Peroxisome Proliferators: Unique Inducers of Drug-Metabolizing Enzymes, ed. by Moody DE. CRC Press, Inc., Boca Raton, FL, pp. 113-121 (1994).
102. Enayetallah AE, French RA, Barber M and Grant DF, Cell-specific subcellular localization of soluble epoxide hydrolase inhuman tissues. J Histochem Cytochem 54:329-335 (2006).
103. Hennebold JD, Mah K, Perez W, Vance JE, Stouffer RL, Morisseau C et al, Identification and characterization of an ovary-selective isoform of epoxide hydrolase. Biol Reprod 72:968-975 (2005).
104. Hammock BD and Ota K, Differential induction of cytosolic epoxide hydrolase, microsomal epoxide hydrolase, and glutathione S-transferase activities. Toxicol App Pharmacol 71:254-265 (1983).
105. Tanaka H, Kamita SG, Wolf NM, Harris TR, Wu Z, Morisseau C et al, Transcriptional regulation of the human soluble expoxide hydrolase gene EPHX2. Biochim Biophys Acta Gene Reg Mech 1779:17-27 (2007).
106. Ai D, Fu Y, Guo D, Tanaka H, Wang N, Tang C et al, Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Proc Natl Acad Sci USA 104:9018-9023 (2007).
107. Mumby SM and Hammock BD, Substrate selectivity and stereochemistry of enzymatic epoxide hydration in the soluble fraction of mouse liver. Pestic Biochem Physiol 11:275-284 (1979).
108. Gill SS and Hammock BD, Hydration of cis- and trans-epoxymethyl stearates by the cytosolic epoxide hydrase of mouse liver. Biochem Biophys Res Commun 89:965-971 (1979).
109. Halarnkar PP, Wixtrom RN, Silva MH and Hammock BD, Catabolism of epoxy fatty esters by the purified epoxide hydrolase from mouse and human liver. Arch Biochem Biophys 272:226-236 (1989).
110. Zeldin DC, Kobayashi J, Falck JR, Winder BS, Hammock BD, Snapper JR et al, Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J Biol Chem 268:6402-6407 (1993).
111. Spector AA and Norris AW, Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol 292:C996-C1012 (2007).
112. Morisseau C, Du G, Newman JW and Hammock BD, Mechanism of mammalian soluble epoxide hydrolase inhibition by chalcone oxide derivatives. Arch Biochem Biophys 356:214-228 (1998).
113. Nakagawa Y, Wheelock CE, Morisseau C, Goodrow MH, Hammock BG and Hammock BD, 3-D QSAR analysis of inhibition of murine soluble epoxide hydrolase (MsEH) by benzoylureas, arylureas, and their analogues. Bioorg Med Chem 8:2663-2673 (2000).
114. Newman JW, Denton DL, Morisseau C, Koger CS, Wheelock CE, Hinton DE et al, Evaluation of fish models of soluble epoxide hydrolase inhibition. Environ Health Persp 109:61-66 (2001).
115. Yu Z, Xu F, Huse LM, Morisseau C, Draper AJ, Newman JW et al, Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res 87:992-998 (2000).
116. Schmelzer KR, Kubala L, Newman JW, Kim IH, Eiserich JP and Hammock BD, Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci USA 102:9772-9777 (2005).
117. Liu Y, Zhang Y, Schmelzer K, Lee TS, Fang X, Zhu Y et al, The anti-inflammatory effect of laminar flow: the role of PPARγ, epoxyeicosatrienoic acids, and soluble epoxide hydrolase. Proc Natl Acad Sci USA 102:16747-16752 (2005).
118. Inceoglu B, Jinks SL, Schmelzer KR, Waite T, Kim IH and Hammock BD, Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain. Life Sci 79:2311-2319 (2006).
119. Schmelzer KR, Inceoglu B, Kubala L, Kim IH, Jinks SL, Eiserich JP et al, Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci USA 103:13646-13651 (2006).
120. Xu D, Li N, He Y, Timofeyev V, Lu L, Tsai HJ et al, Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci USA 103:18733-18738 (2006).
121. Morisseau C, Goodrow MH, Newman JW, Wheelock CE, Dowdy DL and Hammock BD, Structural refinement of inhibitors of urea based soluble epoxide hydrolases. Biochem Pharmacol 63:1599-1608 (2002).
122. Kim IH, Morisseau C, Watanabe T and Hammock BD, Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility. J Med Chem 47:110-2122 (2004).
123. Jones PD, Tsai H-J, Do ZN, Morisseau C and Hammock BD, Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase. Bioorg Med Chem Lett 16:5212-5216 (2006).
124. Hwang SH, Tsai H-J, Liu J-Y, Morisseau C and Hammock BD, Orally bioavailable potent soluble epoxide hydrolase (sEH) inhibitors. J Med Chem 50:3825-3840 (2007).
125. Inceoglu B, Schmelzer KR, Morisseau C, Jinks SL and Hammock BD, Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs). Prostaglandins Other Lipid Mediat 82:42-49 (2007).
126. Guo A, Durner J and Klessig DF, Characterization of a tobacco epoxide hydrolase gene induced during the resistance response to TMV. Plant J 15:647-656 (1998).
127. Croteau R and Kolattukudy PE, Biosynthesis of hydroxy fatty acid polymers. Enzymatic hydration of 18-hydroxy-cis-9,10-epoxystearic acid to threo-9,10,18-trihydroxystearic acid by a particulate preparation from apple (Malus pumila). Arch Biochem Biophys 170:73-81 (1975).
128. Blée E and Schuber F, Occurrence of fatty acid epoxide hydrolases in soybean (Glycine max). Biochem J 282:711-714 (1992).
129. Kiyosue T, Beetham JK, Pinot F, Hammock BD, Yamaguchi-Shinozaki K and Shinozaki K, Characterization of an Aradibopsis cDNA for a soluble epoxide hydrolase gene that is inducible by auxin and water stress. Plant J 6:259-269 (1994).
130. Chiappe C, Leandri E, Hammock BD and Morisseau C, Effect of ionic liquids on epoxide hydrolase-catalyzed synthesis of chiral 1,2-diols. Green Chem 9:162-168 (2007).
131. Van der Werf MJ, Swans HJ and Bont JA, Rhodococcus erythropolis DCL14 contains a novel degradation pathway for limonene. Appl Environ Microbiol 65:2095-2102 (1999).
132. Jacobs MHJ, Wijngaard AJ, Pentenga M and Janssen DB, Characterization of the epoxide hydrolase from epichlorohydrin-degrading Pseudomonas sp. Eur J Biochem 202:1217-1222 (1991).
133. Smit MS and Labuschagné M, Diversity of epoxide hydrolase biocatalysts. Curr Org Chem 10:1145-1161 (2006).
134. Morisseau C, Archelas A, Guitton C, Faucher D, Furstoss R and Baratti JC, Purification and characterization of a highly enantioselective epoxide hydrolase from Aspergillus niger. Eur J Biochem 263:386-395 (1999).
135. Mischitz M, Faber K and Willetts A, Isolation of a highly enantioselective epoxide hydrolase from Rhodococcus sp. NCIMB 11216. Biotech Lett 17:893-898 (1995).
136. Arand M, Haalberg BM, Zou J, Bergfors T, Oesch F, van der Werf MJ et al, Structure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active site. EMBO J 22:2583-2592 (2003).